ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The Ameliorative Effect of COST on Diet-Induced Lipid Metabolism Disorders by Regulating Intestinal Microbiota

You, Huimin; Deng, Xiaoyi; Bai, Yan; He, Jincan; Cao, Hua; Che, Qishi; Guo, Jiao*; Su, Zhengquan*广东药学院
Marine Drugs2022-7DOI: 10.3390/md20070444
4被引6阅读
引用收藏
分享

摘要

Background: Chitosan oligosaccharides, with an average molecular weight <= 1000 Da (COST), is a natural marine product that has the potential to improve intestinal microflora and resist lipid metabolism disorders. Methods: First, by establishing a mice model of lipid metabolism disorder induced by a high fat and high sugar diet, it is proven that COST can reduce lipid metabolism disorder, which may play a role in regulating intestinal microorganisms. Then, the key role of COST in the treatment of intestinal microorganisms is further confirmed through the method of COST-treated feces and fecal bacteria transplantation. Conclusions: intestinal microbiota plays a key role in COST inhibition of lipid metabolism disorder induced by a high fat and high sugar diet. In particular, COST may play a central regulatory role in microbiota, including Bacteroides, Akkermansia, and Desulfovibrio. Taken together, our work suggests that COST may improve the composition of gut microbes, increase the abundance of beneficial bacteria, improve lipid metabolism disorders, and inhibit the development of metabolic disorders.

学科与关键词

关键词
chitosan oligosaccharidesgut microbesdisorders lipid metabolismdiet
相关
加载中…
  • Chitosan oligosaccharide activates brown adipose tissue by modulating the gut microbiota and bile acid pathways based on faecal microbiota transplantation
    Lun, Weijun; Zhou, Jingwen; Bai, Yan; Che, Qishi; Cao, Hua; Guo, Jiao*; Su, Zhengquan*Journal of Functional Foods, 2023, 108: 105731.
  • Anti-Obesity Effect and Mechanism of Chitooligosaccharides Were Revealed Based on Lipidomics in Diet-Induced Obese Mice
    Zhou, Minchuan; Huang, Jingqing; Zhou, Jingwen; Zhi, Cuiting; Bai, Yan; Che, Qishi; Cao, Hua; Guo, Jiao*; Su, Zhengquan*MOLECULES, 2023, 28(14): 5595.
  • Ameliorating the effect and mechanism of chitosan oligosaccharide on nonalcoholic fatty liver disease in mice
    Zhang, Jiahua; Feng, Jiayao; Bai, Yan; Che, Qishi; Cao, Hua; Guo, Jiao*; Su, Zhengquan*Food & Function, 2023, 14(23): 10459-10474.
查看全部 →

发表信息

论文状态
公开发表
期刊
Marine Drugs
发表日期
2022-07
卷期
第 20 卷, 第 7 期
页码
444
DOI
10.3390/md20070444
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Science and Technology Program of Guangzhou, China [202103000089]; Guangdong Demonstration Base for Joint Cultivation of Postgraduates (2019); Science Foundation for Distinguished Young Scholars of Guangdong [2020B1515020026]; National Natural Science Foundation of China [21804025]

作者

  • Y

    You, Huimin (第一作者)

    guangdong pharmaceut univ · new

  • D

    Deng, Xiaoyi

    guangdong pharmaceut univ · new

查看全部 8 位作者收起作者
  • B

    Bai, Yan

    guangdong pharmaceut univ

  • H

    He, Jincan

    guangdong pharmaceut univ

  • C

    Cao, Hua

    guangdong pharmaceut univ

  • C

    Che, Qishi

  • G

    Guo, Jiao (通讯)

    guangdong pharmaceut univ

  • S

    Su, Zhengquan (通讯)

    guangdong pharmaceut univ · new

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417